These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11812918)

  • 21. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Arsenic in food": opinion parading as science.
    Bernard BK
    Environ Health Perspect; 2005 Apr; 113(4):A225; author reply A225-6. PubMed ID: 15811813
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Arsenic carcinogenicity testing.
    Katsnelson BA
    Environ Health Perspect; 1998 Dec; 106(12):A582-3. PubMed ID: 10048943
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitative assay for carcinogen altered differentiation in mouse epidermal cells.
    Kulesz-Martin MF; Koehler B; Hennings H; Yuspa SH
    Carcinogenesis; 1980; 1(12):995-1006. PubMed ID: 11272116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of tumor promotors on cell morphology, population kinetics and differentiation].
    Arenholt D
    Tandlaegebladet; 1984 Oct; 88(17):605-7. PubMed ID: 6596768
    [No Abstract]   [Full Text] [Related]  

  • 27. Global gene expression profiling of hyperkeratotic skin lesions from inner Mongolians chronically exposed to arsenic.
    Bailey K; Xia Y; Ward WO; Knapp G; Mo J; Mumford JL; Owen RD; Thai SF
    Toxicol Pathol; 2009 Dec; 37(7):849-59. PubMed ID: 19841129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clastogenic effects of inorganic arsenic salts on human chromosomes in vitro.
    Chakraborty T; De M
    Drug Chem Toxicol; 2009; 32(2):169-73. PubMed ID: 19514953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
    Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
    Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathological and biochemical aspects of tumour promotion.
    Hicks RM
    Carcinogenesis; 1983 Oct; 4(10):1209-14. PubMed ID: 6616751
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of ochratoxin A on cytotoxicity and cell differentiation in cultured rat embryonic cells.
    Hong JT; Park KL; Han SY; Park KS; Kim HS; Oh SD; Lee RD; Jang SJ
    J Toxicol Environ Health A; 2000 Dec; 61(7):609-21. PubMed ID: 11127415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes.
    Zhou Q; Xi S
    Regul Toxicol Pharmacol; 2018 Nov; 99():78-88. PubMed ID: 30223072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine enhancement of chemical carcinogen-induced transformation of cultured Syrian hamster cells.
    Donovan PJ; DiPaolo JA
    Cancer Res; 1974 Oct; 34(10):2720-7. PubMed ID: 4472019
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.
    Gentry PR; Yager JW; Clewell RA; Clewell HJ
    Toxicol In Vitro; 2014 Oct; 28(7):1196-205. PubMed ID: 24937311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inorganic arsenic: A non-genotoxic carcinogen.
    Cohen SM; Chowdhury A; Arnold LL
    J Environ Sci (China); 2016 Nov; 49():28-37. PubMed ID: 28007178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of arsenic compounds on the in vitro differentiation of mouse embryonic stem cells into cardiomyocytes.
    Wang QQ; Lan YF; Rehman K; Jiang YH; Maimaitiyiming Y; Zhu DY; Naranmandura H
    Chem Res Toxicol; 2015 Mar; 28(3):351-3. PubMed ID: 25166275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemically-induced differentiation of the tumor cell lines].
    Anisimov AG; Volkova TO; Chekmasova AA; Nemova NN
    Ontogenez; 2002; 33(5):325-41. PubMed ID: 12391914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Arsenic: in search of an antidote to a global poison.
    Mead MN
    Environ Health Perspect; 2005 Jun; 113(6):A378-86. PubMed ID: 15929879
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molecular aspects of proliferation and differentiation of human myeloid leukemia cell HL-60].
    Yamada M; Hashinaka K
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):41-53. PubMed ID: 1848717
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance to neoplastic transformation induced by nonterminal differentiation.
    Estervig DN; Maercklein PB; Scott RE
    Cancer Res; 1989 Feb; 49(4):1008-13. PubMed ID: 2912546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.